首页    期刊浏览 2024年12月12日 星期四
登录注册

文章基本信息

  • 标题:Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review
  • 其他标题:Heparin and insulin in the management of hypertriglyceridemia-associated pancreatitis: case series and literature review
  • 本地全文:下载
  • 作者:Kuchay, Mohammad Shafi ; Farooqui, Khalid J. ; Bano, Tarannum
  • 期刊名称:Archives of Endocrinology and Metabolism
  • 印刷版ISSN:2359-3997
  • 出版年度:2017
  • 卷号:61
  • 期号:2
  • 页码:198-201
  • DOI:10.1590/2359-3997000000244
  • 出版社:Archives of Endocrinology and Metabolism
  • 摘要:SUMMARY Severe hypertriglyceridemia accounts for up to 7% of all cases of acute pancreatitis. Heparin and insulin activate lipoprotein lipase (LPL), thereby reducing plasma triglyceride levels. However, the safety and efficacy of heparin and insulin in the treatment of hypertriglyceridemia-associated acute pancreatitis have not been well established yet. We successfully used heparin and insulin as first-line therapy in four consecutive patients with acute pancreatitis secondary to hypertriglyceridemia. In a literature search, we revised almost all reports published to date of patients managed successfully with this combination. Heparin and insulin appear to be a safe, effective, and inexpensive first-line therapy for hypertriglyceridemia-associated acute pancreatitis.
  • 其他摘要:SUMMARY Severe hypertriglyceridemia accounts for up to 7% of all cases of acute pancreatitis. Heparin and insulin activate lipoprotein lipase (LPL), thereby reducing plasma triglyceride levels. However, the safety and efficacy of heparin and insulin in the treatment of hypertriglyceridemia-associated acute pancreatitis have not been well established yet. We successfully used heparin and insulin as first-line therapy in four consecutive patients with acute pancreatitis secondary to hypertriglyceridemia. In a literature search, we revised almost all reports published to date of patients managed successfully with this combination. Heparin and insulin appear to be a safe, effective, and inexpensive first-line therapy for hypertriglyceridemia-associated acute pancreatitis.
国家哲学社会科学文献中心版权所有